Balloon Ablation Catheters Global Market Report 2026

The balloon ablation catheters market size has grown strongly in recent years. It will grow from $1.28 billion in 2025 to $1.4 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing prevalence of cardiac arrhythmias, adoption of minimally invasive ablation procedures, advancements in catheter technologies, rising cardiovascular disease awareness, growth of hospital cardiac care units.

The balloon ablation catheters market size is expected to see strong growth in the next few years. It will grow to $2.04 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing demand for atrial fibrillation treatments, increasing adoption of advanced energy delivery mechanisms, rising use of catheter-based therapies in specialty clinics, expansion of ambulatory surgical centers, increasing integration with imaging and monitoring systems. Major trends in the forecast period include increasing adoption of single-use balloon ablation catheters, rising demand for radiofrequency and cryo balloon catheters, growing focus on minimally invasive cardiac procedures, expansion of reusable balloon ablation catheter applications, rising integration of catheter systems with real-time imaging.

The rising prevalence of cardiac arrhythmias is anticipated to drive the expansion of the balloon ablation catheters market in the coming years. Cardiac arrhythmias are disorders characterized by irregular, excessively rapid, or abnormally slow heartbeats caused by disturbances in the heart’s electrical conduction system. The occurrence of cardiac arrhythmias is increasing primarily due to the aging population, as elderly individuals are more susceptible to heart rhythm abnormalities. Balloon ablation catheters assist in the treatment of cardiac arrhythmias by accurately delivering energy to specific regions of heart tissue to interrupt abnormal electrical pathways, reestablish normal heart rhythm, and lower the risk of complications linked to irregular heartbeats. For example, in March 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government organization, approximately 12.1 million individuals in the United States are expected to be living with atrial fibrillation (AFib) by 2050. Consequently, the increasing prevalence of cardiac arrhythmias is fueling the growth of the balloon ablation catheters market.

Key companies operating in the balloon ablation catheters market are concentrating on developing innovative products such as next-generation pulsed field ablation catheters to enhance safety, reduce procedure time, and improve patient outcomes. Next-generation pulsed field ablation catheters are advanced balloon-based devices that deliver precise electrical pulses to treat abnormal heart rhythms, helping to shorten procedure duration, limit tissue damage, and improve patient recovery. For example, in December 2025, Abbott Laboratories, a US-based medical device company, received U.S. Food and Drug Administration approval for the Volt Pulsed Field Ablation System, an innovative balloon-in-basket pulsed field ablation (PFA) catheter integrated with the EnSite X electroanatomical mapping system. The device allows clinicians to map, pace, and ablate cardiac tissue using a single catheter, delivering precise, non-thermal energy to create targeted lesions while limiting damage to surrounding tissue. Its balloon-in-basket configuration, incorporating multiple active splines, ensures optimal tissue contact and consistent energy delivery, enhancing procedural efficiency and safety compared with conventional thermal ablation catheters. Developed for the treatment of both paroxysmal and persistent atrial fibrillation, the system decreases procedure times and facilitates faster patient recovery.

In October 2025, Merit Medical Systems Inc., a United States-based healthcare technology company, purchased the C2 CryoBalloon device along with its associated technology from PENTAX Medical for an undisclosed sum. Through this acquisition, Merit Medical intends to broaden its endoscopy product portfolio and reinforce its position in the gastroenterology market by delivering minimally invasive therapeutic solutions for conditions such as Barrett’s esophagus and other gastrointestinal disorders. PENTAX Medical is a Japan-based healthcare technology company that focuses on supplying the C2 cryoballoon ablation system.

Major companies operating in the balloon ablation catheters market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Toray Industries Inc., Boston Scientific Corporation, Cook Medical LLC, Biotronik SE & Co. KG, Merit Medical Systems Inc., CONMED Corporation, Lepu Medical Technology (Beijing) Co. Ltd., MicroPort Scientific Corporation, Avanos Medical Inc., Japan Lifeline Co. Ltd., AngioDynamics Inc., Imricor Medical Systems Inc., Kardium Inc., B. Braun SE, ERBE Elektromedizin GmbH, CathVision A/S, Osypka AG, CathRx Ltd., Pulse Biosciences Inc., CardioNXT Inc., Shanghai MicroPort EP MedTech Co. Ltd., Aurigen Medical Inc.

North America was the largest region in the balloon ablation catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon ablation catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the balloon ablation catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The balloon ablation catheters market consists of sales of cryoballoon ablation catheters, radiofrequency balloon ablation catheters, laser balloon ablation catheters, single-use balloon catheters, and multi-electrode balloon catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Balloon ablation catheters are specialized medical devices that integrate an inflatable balloon with energy delivery mechanisms, such as radiofrequency, cryo, laser, or thermal elements, at the catheter tip. They are designed to perform precise tissue ablation by inflating the balloon to isolate target areas while delivering energy to create circumferential lesions that interrupt abnormal electrical pathways.

The key product types of balloon ablation catheters include single-use balloon ablation catheters and reusable balloon ablation catheters. Single-use balloon ablation catheters are designed to deliver controlled energy to cardiac tissue to treat abnormal heart rhythms in a single procedure. They are used in cardiac arrhythmia, atrial fibrillation, ventricular tachycardia, and other applications, serving hospitals, ambulatory surgical centers, specialty clinics, and other end-users.

Tariffs on imported medical devices, precision components, and energy delivery modules are impacting the balloon ablation catheter market by raising costs for single-use and reusable catheters, particularly affecting hospitals and specialty clinics in North America, Europe, and Asia-Pacific. While tariffs increase procurement expenses, they also incentivize local manufacturing, stimulate domestic R&D, and encourage the development of cost-optimized and high-precision catheter solutions, supporting long-term market growth and supply chain resilience.

The balloon ablation catheters market research report is one of a series of new reports that provides balloon ablation catheters market statistics, including balloon ablation catheters industry global market size, regional shares, competitors with a balloon ablation catheters market share, detailed balloon ablation catheters market segments, market trends and opportunities, and any further data you may need to thrive in the balloon ablation catheters industry. This balloon ablation catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.